Aura Biosciences Inc (NAS:AURA)
$ 6.97 +0.11 (+1.6%) Market Cap: 720.95 Mil Enterprise Value: 623.21 Mil PE Ratio: 0 PB Ratio: 4.17 GF Score: 34/100

Aura Biosciences Inc at TD Cowen Healthcare Conference Transcript

Mar 4, 2026 / 02:10 PM GMT
Release Date Price: $6.15 (-1.44%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

AURA.OQ - Aura Biosciences Inc
Aura Biosciences Inc at TD Cowen Healthcare Conference
Mar 04, 2026 / 02:10PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning and welcome once again to TD Cowan's forty-sixth annual Healthcare conference. I'm Phil Nado, one of the biotech analysts here at Cowan. It's my pleasure to moderate a fireside chat with Aura. This morning, we have with us Ellie De Los Pinos, the founder and CEO. Ellie, I'll hand it to you to begin. Can you give us a state of the company? What are the biggest strengths, biggest challenges, and what does AurA need to do to create shareholder value over the next year or two?

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Yes, it's a pleasure to be here.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot